|
Title |
Neuroprotective interventions in in vitro models of hypoxic-ischaemic injury: A review
|
|
Authors |
Rashmi Singla1, Arsalan Moinuddin2,*, Ashish Goel2 & Deepak Goel3
|
|
Affiliation |
1Department of Pharmacology, Shri Guru Ram Rai Institute of Medical & Health Sciences, SGRR University, Dehradun, India; 2Department of Physiology, Shri Guru Ram Rai Institute of Medical & Health Sciences, SGRR University, Dehradun, India; 3Department of Neurology, Himalayan Institute of Medical Sciences, SRHU, Dehradun, India; *Corresponding author
|
|
|
Rashmi Singla - E-mail: singlarashmi@gmail.com
|
|
Article Type |
Review
|
|
Date |
Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026
|
|
Abstract |
Ischaemic-reperfusion injury after stroke involves oxidative stress, mitochondrial dysfunction and regulated cell death, creating a need for effective neuroprotective targets. Therefore, it is of interest to examine the recent evidence from 2024 to August 2026 on Nrf2-related neuroprotective interventions, with emphasis on SH-SY5Y oxygen-glucose deprivation/reoxygenation models. Recent studies indicate that Nrf2 activation may reduce oxidative stress, preserve mitochondrial function and regulate apoptosis, autophagy, mitophagy and ferroptosis through pathways involving Keap1-Nrf2, Nrf2/HO-1 and Nrf2/GPX4 signalling. Nrf2 therefore represents an important experimental target for neuroprotection, although validation in standardized and more human-relevant models is required before clinical translation. |
|
Keywords |
Nrf2, SH-SY5Y, oxygen-glucose deprivation or reoxygenation, neuroprotection, ischaemia-reperfusion, ferroptosis
|
|
Citation |
Singla et al. Bioinformation 22(10): 6965-6968 (2026)
|
|
Edited by |
P Kangueane
|
|
ISSN |
0973-2063
|
|
Publisher |
|
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|
|
|